The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia
Am J Prev Med. 2020 Oct 1;S0749-3797(20)30272-5. doi: 10.1016/j.amepre.2020.05.022.Online ahead of print.
Stacy Tressler1, Christa Lilly2, Diane Gross3, Thomas Hulsey4, Judith Feinberg5
Author information
1Department of Epidemiology, West Virginia University, Morgantown, West Virginia; Monongalia County Health Department, Morgantown, West Virginia. Electronic address: sriffee@mix.wvu.edu.
2Department of Biostatistics, West Virginia University, Morgantown, West Virginia.
3Department of Epidemiology, West Virginia University, Morgantown, West Virginia; Monongalia County Health Department, Morgantown, West Virginia.
4Department of Epidemiology, West Virginia University, Morgantown, West Virginia.
5Department of Behavioral Medicine and Psychiatry, West Virginia University, Morgantown, West Virginia; Department of Neuroscience, West Virginia University, Morgantown, West Virginia; Division of Infectious Diseases, Department of Medicine, West Virginia University, Morgantown, West Virginia.
Abstract
Introduction: West Virginia leads the nation with the highest rate of acute hepatitis B. From 2013 to 2015, the West Virginia hepatitis B Vaccination Pilot Project distributed more than 10,000 doses of hepatitis B vaccine to at-risk adults through local health department clinics and through outreach to correctional facilities and substance use treatment centers. This study aims to determine which setting type is associated with the greatest likelihood of at-risk adults receiving all 3 or at least 2 doses of hepatitis B vaccine.
Methods: Data for this retrospective cohort study were accessed, extracted, and analyzed in 2019 from Pilot Project participant forms initially completed from 2013 to 2015. Odds of receiving all 3 or at least 2 doses were calculated using bivariate, multivariable, and mixed-effects regression models.
Results: Data were available for 1,201 participants. In multivariable logistic regression, participants vaccinated at substance use treatment centers (AOR=1.37, 95% CI=1.01, 1.86) and local health department family planning clinics (AOR=3.74, 95% CI=1.98, 7.06) were more likely to receive the 3-dose series versus those vaccinated at local health department sexually transmitted disease clinics. Participants vaccinated through substance use treatment centers (AOR=1.79, 95% CI=1.31, 2.44), correctional facilities (AOR=3.34, 95% CI=2.09, 5.34), and local health department family planning clinics (AOR=3.97, 95% CI=1.72, 9.16) were more likely to receive at least 2 doses.
Conclusions: Hepatitis B vaccination delivered at local health department family planning clinics, substance use treatment centers, or correctional facilities may increase vaccine dose completion in West Virginia.